Surmodics Reports Sex-Specific PROWL Study Results with Pounce™
Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving...
KalVista to Share EKTERLY® Data at Allergy & Immunology 2025
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral...
Thousand Oaks Biologics Highlights ADC CRDMO Solutions at CPHI 2025
Thousand Oaks Biologics, a leading Asia-based CRDMO specializing in macromolecules, today announced its participation in...
Louisianans Can Get Free Lung Cancer Screening in Awareness Month
The Louisiana Lung Cancer Screening Initiative will offer free lung cancer screenings to eligible Louisiana...
Neurotronic Reports First Outcomes of Multi‑Organ Denervation in T2D
Groundbreaking results from two NECTAR trials to be presented at TCT 2025 Neurotronic, Inc., a developer...
Innovent’s Mazdutide Beats Semaglutide in Glycemic & Weight Loss
Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...